Method for increasing the yield of antibodies in the techniques

Details Method for increasing the yield of antibodies in the techniques Method for increasing the yield of antibodies in the techniques

1998-04-10

2000-07-04

Minnifield, Nita

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

4241841, 424614, 424724, 424450, 514494, 514499, 5303881, 5303891, A61K 4500, A61K 9127, A01N 3900, A01N 5900, A01N 5502

Patent

active

060835133

ABSTRACT:
The improved method uses N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) or N-acetylglucosaminyl-N-acetyl-muramyl-L-alanyl-D-isoglutamine (GMDP) in low dose ranges in a combination with zinc-L-proline complex and with immunostimulating lipid in doses which synergistically potentiate the effect of each single component whereby the zinc-L-proline complex contains an excess of L-proline or 5-oxo-L-proline which serves as a solubilizer and dispersing agent for the lipid component.

REFERENCES:
patent: 4036953 (1977-07-01), Adam et al.
patent: 4094971 (1978-06-01), Chedid et al.
patent: 4395399 (1983-07-01), Ovchinnikov et al.
patent: 4578269 (1986-03-01), Morein
patent: 4801578 (1989-01-01), Monsigny et al.
patent: 4845042 (1989-07-01), Newman et al.
patent: 4877612 (1989-10-01), Berger et al.
patent: 5109026 (1992-04-01), Hoskinsone et al.
patent: 5376369 (1994-12-01), Allison et al.
patent: 5409698 (1995-04-01), Anderson et al.
patent: 5416070 (1995-05-01), Vosika et al.
patent: 5773011 (1998-06-01), Grubhofer
patent: 5919466 (1999-07-01), Grubhofer
patent: 6004564 (1999-12-01), Grubhofer
Byars, Noelene E., et al. (1987) "Adjuvant formulation for use in vaccines to elicit both cell-mediated and humor immunity", Vaccine, 5:223-228.
Grubhofer, N. (1995) "An adjuvant formulation based on N-acetylglucosaminyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with dimethyldiotadecylammonium chloride and zinc-L-proline complex as synergists", Immunology Letters, 44:19-24.
Vogel, F.R., et al. (1995) "A Compendium of Vaccine Adjuvants and Excipients", in: Vaccine Design, M.F. Powell & M.J. Newman Eds. Plenum publishing Corp NY in press.
Arakawa et al 1993. Adv. Drug Delivery Rev. 10:1-28.
Fesdorf et al 1935. J. Immunol. 29:389-425.
Hilgers et al 1986 Int. Archs. Allergy Appl Immunol 79:392-96.
Nesmeyanor et al. 1990 Biomedical Science 1(2):151-154.
Abeshira-Amar et al 1987 Mol. Immunol 24(9):945-51.
Nash et al, 1985. J. Reprod. Immunol. 7:151-162.
Sharma et al, 1988 Tech. Adv. in Vacc. Dev. pp. 107-116.
Shimizu et al 1992. Int. J. Immunopharm. 14(8):1415-20.
Audibert et al, 1977, Ann. Immunol 128C: 653-61.
Andronova et al, 1991, Sov. Med. Rev. D.Immunol. 4:1-63.
Auci et al 1993, Int. Arch. AllergyImmunol, 101:167-176.
Khullar et al, 1988 Immunol Invest. 17(1): 1-17.
Ott et al, 1995. In: Vaccine Design: The subunit and Adjuvant Approach Ed. Powell et al. Plenum Press NY pp. 277-295.
Bomford 1992. Med. Virol. 2:169-174.
Carelli et al, 1981, Inf & Imm. 33(1):312-314.
Alam et al, 1991 Immunol. Lett. 27:53-58.
Teerlink et al, 1987, Vaccine 5:307-314.
Edelman et al, 1990, Intern. Rev. Immunol. 7:51-66.
Grubhofer et al 1993. In: Animal Cell Technology: Basic & Applied Aspects, vol. 5:557-564, Eds: Kaminogawa et al.
Hilgers et al, 1992. Res. Immunol, 143:494-503.
Grubhofer et al, 1994, FASEBJ. 8(4-5):A993.
Allison et al 1988 Tech. Adv. Vacc Dev. pp. 401-409.
Bennett et al. 1992. J. Immunol, Methods. 153:31-40.
Tsujimoto et al, 1986, Inf & Imm. 53(3):511-516.
Allison et al, 1986, J. Immunol. Methods, 95:157-168.
Gregeriadis et al 1989. Immunol Lett. 20:237-240.
Yin et al 1989. J. Biological Resp. Modifiers 8:190-205.
Esher et al, 1974, J. Nat'l Cancer Institute 5391):209-212.
Desowitz et al, et al, 1980. Inf & Imm. 27(1):87-89.
Wong et al, 1976, Int. Arch Allergy Appl. Imm. 50:155-163.
Dzata et al, 1991, Vet. Microbiol, 29:15-26.
Audibert et al, 1984, Inf. & Imm. 45(1):261-66.
Richards et al, 1988, Inf & Imm. 56(3):682-686.
Warren et al, 1986, Ann. Rev.Immunol. 4:369-88.
Stanfield et al 1973. The Lancet Feb. 3, 1973 pp. 215-219.

Affiliated with

Also associated with

Rating

Method for increasing the yield of antibodies in the techniques does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for increasing the yield of antibodies in the techniques , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for increasing the yield of antibodies in the techniques will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1483549